High materiality7/10
Truist Securities Assumes Zymeworks (ZYME) at Buy
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
ZYME target $28; current price $23.93; Truist initiates Buy.
- ZYME target $28; Price $23.93.
Key facts
- 01
Target: $28
- 02
Posted price: $23.93
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.